Physician profile
Greg Pearl
NPI 1639232838
$6,153.63
in general payments reported to CMS, 2019-2025
10 companies · $616 in 2025
The $616 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $468 · 2020: $155 · 2021: $402 · 2022: $640 · 2023: $207 · 2024: $3,666 · 2025: $616.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,795 · Food and Beverage: $1,694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,795.42 |
| Food and Beverage | $1,693.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $4,513.16 | 2019-2025 | Dailies Total1, Total30, Precision 1 |
| Johnson & Johnson Vision Care, INC. | $469.68 | 2019-2025 | Acuvue |
| Glaukos Corporation | $426.96 | 2021-2025 | Idose, Idosetr |
| Coopervision INC. | $262.48 | 2019-2021 | |
| Optos, INC. | $175.19 | 2022 | |
| Kala Pharmaceuticals, INC. | $143.16 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $73.63 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $50.89 | 2022-2024 | Infuse |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Tactile Systems Technology INC | $19.08 | 2025 | Nimbl, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Greg Pearl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.